CN101932600B - 修饰的生长激素多肽 - Google Patents
修饰的生长激素多肽 Download PDFInfo
- Publication number
- CN101932600B CN101932600B CN200880106595.1A CN200880106595A CN101932600B CN 101932600 B CN101932600 B CN 101932600B CN 200880106595 A CN200880106595 A CN 200880106595A CN 101932600 B CN101932600 B CN 101932600B
- Authority
- CN
- China
- Prior art keywords
- ser
- leu
- glu
- thr
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97901007P | 2007-10-10 | 2007-10-10 | |
| US60/979,010 | 2007-10-10 | ||
| GBGB0719818.7A GB0719818D0 (en) | 2007-10-11 | 2007-10-11 | Growth hormone fusion polypeptides |
| GB0719818.7 | 2007-10-11 | ||
| PCT/GB2008/003056 WO2009047474A2 (en) | 2007-10-10 | 2008-09-10 | Modified growth hormone polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101932600A CN101932600A (zh) | 2010-12-29 |
| CN101932600B true CN101932600B (zh) | 2014-05-28 |
Family
ID=38787949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880106595.1A Expired - Fee Related CN101932600B (zh) | 2007-10-10 | 2008-09-10 | 修饰的生长激素多肽 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8273552B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2886553A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5697983B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100067686A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101932600B (cg-RX-API-DMAC7.html) |
| AR (1) | AR068038A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008309386A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0818639A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2701369A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2209798T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2532600T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0719818D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL203073A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2010003892A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2471808C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200918098A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009047474A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0606946D0 (en) * | 2006-04-06 | 2006-05-17 | Asterion Ltd | Polypeptide antagonist |
| GB201104285D0 (en) | 2011-03-15 | 2011-04-27 | Asterion Ltd | Modified receptor fusion proteins |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001096565A2 (en) * | 2000-06-16 | 2001-12-20 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
| WO2003070765A2 (en) * | 2001-12-14 | 2003-08-28 | Asterion Limited | Growth hormone fusion protein |
| WO2004090135A2 (en) * | 2003-04-09 | 2004-10-21 | Asterion Limited | Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH20A (fr) * | 1888-12-05 | Joseph Magnat | Une pompe à bière automatique fonctionnant par la pression de l'eau | |
| ATE455171T1 (de) * | 1995-09-21 | 2010-01-15 | Genentech Inc | Varianten des menschlichen wachstumshormons |
| GB0018891D0 (en) * | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
| ATE509097T1 (de) | 2001-11-21 | 2011-05-15 | Us Health | Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna |
| MX2007001180A (es) * | 2004-07-26 | 2007-04-13 | Asterion Ltd | Enlazantes. |
| GB0717985D0 (en) | 2007-07-20 | 2007-10-24 | Asterion Ltd | Growth hormone fusion proteins |
| EP2288386A1 (en) * | 2008-02-19 | 2011-03-02 | Asterion Limited | Modified linkers |
-
2007
- 2007-10-11 GB GBGB0719818.7A patent/GB0719818D0/en not_active Ceased
-
2008
- 2008-08-20 TW TW097131758A patent/TW200918098A/zh unknown
- 2008-08-26 AR ARP080103700A patent/AR068038A1/es not_active Application Discontinuation
- 2008-09-10 WO PCT/GB2008/003056 patent/WO2009047474A2/en not_active Ceased
- 2008-09-10 ES ES08788565.3T patent/ES2532600T3/es active Active
- 2008-09-10 EP EP14197613.4A patent/EP2886553A1/en not_active Withdrawn
- 2008-09-10 MX MX2010003892A patent/MX2010003892A/es not_active Application Discontinuation
- 2008-09-10 US US12/678,282 patent/US8273552B2/en not_active Expired - Fee Related
- 2008-09-10 KR KR1020107010215A patent/KR20100067686A/ko not_active Ceased
- 2008-09-10 CA CA2701369A patent/CA2701369A1/en not_active Abandoned
- 2008-09-10 BR BRPI0818639 patent/BRPI0818639A2/pt not_active Application Discontinuation
- 2008-09-10 RU RU2010103159/10A patent/RU2471808C2/ru not_active IP Right Cessation
- 2008-09-10 CN CN200880106595.1A patent/CN101932600B/zh not_active Expired - Fee Related
- 2008-09-10 AU AU2008309386A patent/AU2008309386A1/en not_active Abandoned
- 2008-09-10 EP EP08788565.3A patent/EP2209798B1/en not_active Not-in-force
- 2008-09-10 JP JP2010528468A patent/JP5697983B2/ja not_active Expired - Fee Related
- 2008-09-10 DK DK08788565T patent/DK2209798T3/en active
-
2009
- 2009-12-31 IL IL203073A patent/IL203073A0/en unknown
-
2012
- 2012-08-22 US US13/592,252 patent/US20120322735A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001096565A2 (en) * | 2000-06-16 | 2001-12-20 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
| WO2003070765A2 (en) * | 2001-12-14 | 2003-08-28 | Asterion Limited | Growth hormone fusion protein |
| WO2004090135A2 (en) * | 2003-04-09 | 2004-10-21 | Asterion Limited | Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
Non-Patent Citations (2)
| Title |
|---|
| Pegvisomant:a growth hormone receptor antagonist for the treatment of acromegaly;Parkinson C et al;《Growth Hormone and IGF Research》;20000401;第10卷;s119-s123 * |
| Tandem fusion of growth hormone and its G120R mutated antagonist retain biological activity and demonstrate prolonged plasma half-life;Pradhananga S L et al;《Growth Hormone and IGF Research》;20040401;第14卷(第2期);116 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101932600A (zh) | 2010-12-29 |
| BRPI0818639A2 (pt) | 2015-04-07 |
| AR068038A1 (es) | 2009-10-28 |
| EP2209798A2 (en) | 2010-07-28 |
| WO2009047474A2 (en) | 2009-04-16 |
| CA2701369A1 (en) | 2009-04-16 |
| US20100197589A1 (en) | 2010-08-05 |
| US8273552B2 (en) | 2012-09-25 |
| JP5697983B2 (ja) | 2015-04-08 |
| IL203073A0 (en) | 2010-11-30 |
| WO2009047474A3 (en) | 2010-09-02 |
| GB0719818D0 (en) | 2007-11-21 |
| JP2011507487A (ja) | 2011-03-10 |
| ES2532600T3 (es) | 2015-03-30 |
| MX2010003892A (es) | 2010-05-17 |
| DK2209798T3 (en) | 2015-03-23 |
| KR20100067686A (ko) | 2010-06-21 |
| TW200918098A (en) | 2009-05-01 |
| US20120322735A1 (en) | 2012-12-20 |
| EP2209798B1 (en) | 2014-12-31 |
| EP2886553A1 (en) | 2015-06-24 |
| AU2008309386A1 (en) | 2009-04-16 |
| RU2471808C2 (ru) | 2013-01-10 |
| RU2010103159A (ru) | 2011-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108570109B (zh) | 包含免疫球蛋白Fc部分的双靶点融合蛋白 | |
| EP0728147B1 (en) | Receptor specific atrial natriuretic peptides | |
| US5665704A (en) | Receptor specific atrial natriuretic peptides | |
| CN101679504B (zh) | 生长激素融合蛋白 | |
| KR100879553B1 (ko) | 변형 폴리펩티드 | |
| TW202225183A (zh) | Gdf15融合蛋白及其用途 | |
| CN101268099A (zh) | 用于治疗性干预的y4选择性受体激动剂 | |
| US5736363A (en) | IGF-II analogues | |
| Puett et al. | hCG-receptor binding and transmembrane signaling | |
| RU2325400C2 (ru) | Мультимеры рецептор-связывающих лигандов | |
| CN101932600A (zh) | 修饰的生长激素多肽 | |
| IL285930B2 (en) | RECOMBINANT CCN PROTEIN FIELD AND PROTEIN FUSION | |
| CN101389649A (zh) | 多肽拮抗剂 | |
| CN116948037A (zh) | 一种新结构长效卵泡刺激素重组蛋白及其制备和应用 | |
| CN101827859A (zh) | 胰岛素样生长因子融合蛋白 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20150910 |
|
| EXPY | Termination of patent right or utility model |